EQUITAPE 90 MG/G ORAL GEL FOR HORSES
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
02-05-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
PRAZIQUANTEL
Inapatikana kutoka:
Bayer Limited
ATC kanuni:
QP52AA01
INN (Jina la Kimataifa):
PRAZIQUANTEL
Kipimo:
90 mg/g
Dawa fomu:
Oral Gel
Dawa ya aina:
LM-Licensed Merchant
Kundi la matibabu:
Equine - Food
Eneo la matibabu:
Praziquantel
Matibabu dalili:
Endoparasiticide
Idhini hali ya:
Authorised
Idhini ya tarehe:
2002-02-08
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Equitape 90 mg/g Oral Gel for Horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Praziquantel …………………...........................90.0 mg
EXCIPIENTS
Propyl Parahydroxybenzoate (E 216) …………0.2 mg
Methyl Parahydroxybenzoate (E 218) …………1.4 mg
Excipients ad……………………………………1.0 g
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral Gel.
White soft gel.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horse.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections with cestodes of the species _Anoplocephala perfoliata_, sensitive to praziquantel.
4.3 CONTRAINDICATIONS
None known.
Milk: see section 4.11.
(Do not use in mares from which milk is taken for human consumption).
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 06/01/2012_
_CRN 7011335_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As tapeworm infestation is unlikely to occur in horses before two months of age, treatment of foals below this age is
not considered necessary.
In order to limit excretion of the product and its metabolites on the pasture horses should remain stabled for 2 days after
treatment.
Parasite resistance to a particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic
of that class.
MRLs for milk have not been established.
See section 4.11 Withdrawal periods.
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCTS TO ANIMALS
Wash hands thoroughly after treating animals.
Any spillage of the product
Soma hati kamili
